Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO7795081 safety and drug-drug interaction study in obesity or overweight
NL-OMON58885Phase 1Active, not recruiting
- Sponsor
- Roche
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-arm trial of RO7795081 in obesity and Overweight, sponsored by Roche. Started May 2025; status: active, not recruiting.
02
Drugs
RO7795081
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NL-OMON58885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58885.